Posters: Poster Session 1
Thursday September 18, 2025 from 17:00 to 18:00
MOA 10 (Exhibit Area)
Lectures
  • 3 Prevalence and risk factors for pseudotumor cerebri syndrome in pediatric kidney transplant patients
    Dr. Sandra Amaral, United States
  • 7 Novel biomarkers predictive for graft dysfunction – a pilot study using machine learning prediction as an AI tool
    Mrs. Andreea-Liana Bot Rachisan, Romania
  • 10 Clinicopathological Features Associated with Allograft Failure in FSGS Recurrence
    Dr. Olga Charnaya, United States
  • 11 Renal Cell Carcinoma in a Pediatric Kidney Transplant Recipient
    Dr. Heeyeon Cho, Korea
  • 15 Pediatric to adult transition: Analysis of a standardized assessment protocol for kidney transplant patients
    Jon Garrison, United States
  • 16 Outcomes of paediatric kidney transplant: A single centre experience from Sri Lanka
    Dr. Vindya N Gunasekara Sr., Sri Lanka
  • 19 Long-term outcomes of kidney transplantation in pediatric patients with CAKUT and Non-CAKUT
    Mr. Lin Lang, People's Republic of China
  • 24 Low incidence of rejection and de novo donor-specific antibody formation following covid-19 vaccination or infection among pediatric kidney transplant recipients
    Helen Pizzo, United States
  • 25 Phenotypic expansion of CRB2-related disease in monozygotic twins with multisystem involvement and severe post-transplant complications: Case report and literature review
    Dr. Moran Plonsky Toder, Israel
  • 26 Cardiovascular profile of children with end-stage kidney disease prior to living donor kidney transplantation
    Dr. Henny A Puspitasari, Indonesia
  • 27 Evaluating Recurrent Glomerulonephritis in Kidney Transplantation
    Dr. Rupesh Raina, United States
  • 29 Outcomes and challenges in paediatric kidney transplantation in small recipients: a 20-year retrospective study
    Dr. Thozama V Siyotula, South Africa
  • 36 Living donor liver transplantation outcomes in Pediatric patients with liver decompensation secondary to Budd-Chiari Syndrome: A single center experience.
    Dr. Haider Ali, Pakistan
  • 38 Auxiliary Partial Orthotopic Liver Transplantation (APOLT) in Pediatric Patients with Crigler-Najjar Syndrome: A Single-Center Experience
    Dr. Syed Muhammad Talha Bukhari, Pakistan
  • 40 Vascular complications in children receiving a size-match whole liver transplant
    Ms. Irene Dieguez, United Kingdom
  • 46 Pediatric liver transplantation in Korea: Improving outcomes in recent decades
    Prof. Sanghoon Lee, Korea
  • 48 Uncommon but Fatal: Early Immunological Complications After Pediatric Liver Transplantation and Their Impact on Survival
    Dr. Małgorzata Markiewicz-Kijewska, Poland
  • 49 Pediatric ACLF, Optimizing Outcomes Through Timely Living Donor Liver Transplantation.
    Dr. Muhammad Amar Qudeer, Pakistan
  • 53 Results of duct-to-duct biliary reconstruction in pediatric liver transplantation: Single center experience
    Dr. Maria Velayos, Spain
  • 58 An exploration of scar management in pediatric heart transplant: A quality improvement project
    Alison Schwartz, Canada
  • 60 Use of parenteral nutrition prior to heart transplantation for Protein-losing enteropathy related to Fontan circulation: patient and clinician perspectives at critical timepoints
    Mrs. Amy Andrews, New Zealand
  • 62 Investigating the modifiable psychosocial variables influencing access to and outcomes after kidney transplantation in children: preliminary findings of a longitudinal study
    Ji Soo Kim, United Kingdom
  • 68 Perioperative efficacy study of recombinant humanized anti-CD25 monoclonal antibody for immunoinduction in pediatric liver transplant recipients
    Dr. Jianxin Xi, People's Republic of China
  • 75 Toward zero waitlist mortality: A mixed-methods review of loss of life while awaiting pediatric liver transplant
    Dr. Joshua E Gossett, United States

© 2025 IPTA 2025